The serotonergic system in mood disorders and suicidal behaviour

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1615, 2013, Pages

  John Mann, J ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Mood disorders; Serotonin; Suicide

Indexed keywords

ABNORMALITY; AGGRESSION; BRAIN; DECISION MAKING; FUNCTIONAL ROLE; HORMONE; MEDICINE; MENTAL HEALTH; NERVOUS SYSTEM DISORDER; NEUROLOGY; PHYSIOLOGY; SUICIDE;

EID: 84874544465     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0537     Document Type: Article

References (108)

1. Mann JJ, Waternaux C, Haas GL, Malone KM. 1999 Toward a clinical model of suicidal behavior in psychiatric patients. Am. J. Psychiat. 156, 181-189.
2. Melhem NM et al. 2007 Familial pathways to earlyonset suicidal behavior: familial and individual antecedents of suicidal behavior. Am. J. Psychiat. 164, 1364-1370. (doi:10.1176/appi.ajp.2007.06091522)
3. Kety SS. 1986 Genetic factors in suicide. In Suicide (ed. A Roy), pp. 41-45. Baltimore, MD: Williams & Wilkins.
4. Roy A, Nielsen D, Rylander G, Sarchiapone M, Segal N. 1999 Genetics of suicide in depression (Review). J. Clin. Psychiat. 60(Suppl. 2), S12-SS7.
5. Roy A, Segal NL, Centerwall BS, Robinette CD. 1991 Suicide in twins. Arch. Gen. Psychiat. 48, 29-32. (doi:10.1001/archpsyc.1991.01810250031003)
6. Roy A, Segal NL, Sarchiapone M. 1995 Attempted suicide among living co-twins of twin suicide victims. Am. J. Psychiat. 152, 1075-1076.
7. Statham DJ, Heath AC, Madden PA, Bucholz KK, Bierut L, Dinwiddie SH, Slutske WS, Dunne MP, Martin NG. 1998 Suicidal behaviour: an epidemiological and genetic study. Psychol. Med. 28, 839-855. (doi:10.1017/S0033291798006916)
8. McGuffin P et al. 2005 Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum. Mol. Genet. 14, 3337-3345.(doi:10.1093/hmg/ddi363)
9. Zubenko GS, Maher BS, Hughes III HB, Zubenko WN, Scott SJ, Marazita ML. 2004 Genome-wide linkage survey for genetic loci that affect the risk of suicide attempts in families with recurrent, early-onset, major depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 129, 47-54. (doi:10.1002/ajmg.b.30092)
10. Laje G, Allen AS, Akula N, Manji H, John Rush A, McMahon FJ. 2009 Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. Pharmacogenet. Genomics 19, 666-674. (doi:10.1097/FPC.0b013e32832e4bcd)
11. Perlis RH et al. 2010 Genome-wide association study of suicide attempts in mood disorder patients. Am. J. Psychiat. 167, 1499-1507. (doi:10.1176/appi.ajp.2010.10040541)
12. Schosser A et al. 2011 Genomewide association scan of suicidal thoughts and behaviour in major depression. PloS ONE 6, e20690. (doi:10.1371/journal.pone.0020690)
13. Mann JJ et al. 2009 Candidate endophenotypes for genetic studies of suicidal behavior. Biol. Psychiat. 65, 556-563. (doi:10.1016/j.biopsych.2008.11.021)
14. Mann JJ et al. 2005 Suicide prevention strategies: a systematic review. J. Am. Med. Assoc. 294, 2064-2074. (doi:10.1001/jama.294.16.2064)
15. Arsenault-Lapierre G, Kim C, Turecki G. 2004 Psychiatric diagnoses in 3275 suicides: a metaanalysis. BMC Psychiat. 4, 37. (doi:10.1186/1471-244X-4-37)
16. Schneider B, Wetterling T, Sargk D, Schneider F, Schnabel A, Maurer K, Fritze J. 2006 Axis I disorders and personality disorders as risk factors for suicide. Eur. Arch. Psychiatry Clin. Neurosci. 256, 17-27.(doi:10.1007/s00406-005-0593-7)
17. McGirr A, Renaud J, Seguin M, Alda M, Benkelfat C, Lesage A, Turecki G. 2007 An examination of DSMIV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study. J. Affect. Disord. 97, 203-209. (doi:10.1016/j.jad.2006.06.016)
18. Scott CL, Swartz E, Warburton K. 2006 The psychological autopsy: solving the mysteries of death. Psychiat. Clin. North Am. 29, 805-822. (doi:10.1016/j.psc.2006.04.003)
19. Charney DS. 1998 Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiat. 59(Suppl. 14), 11-14.
20. Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP. 2006 Can biological tests assist prediction of suicide in mood disorders? Int. J. Neuropsychopharmacol. 9, 465-474. (doi:10.1017/S1461145705005687)
21. van Praag HM. 1983 CSF 5-HIAA and suicide in nondepressed schizophrenics. Lancet 322, 977-978.(doi:10.1016/S0140-6736(83)90501-9)
22. Ninan PT, van Kammen DP, Scheinin M, Linnoila M, Bunney Jr WE, Goodwin FK. 1984 CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. Am. J. Psychiat. 141, 566-569.
23. Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA. 2006 A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disord. 8, 543-550.(doi:10.1111/j.1399-5618.2006.00319.x)
24. Asberg M. 1997 Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann. N Y Acad. Sci. 836, 158-181. (doi:10.1111/j.1749-6632.1997.tb52359.x)
25. Mann JJ, Arango V, Underwood MD. 1990 Serotonin and suicidal behavior. Ann. N Y Acad. Sci. 600, 476-484. (doi:10.1111/j.1749-6632.1990.tb16903.x)
26. Stockmeier CA. 2003 Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J. Psychiat. Res. 37, 357-373. (doi:10.1016/S0022-3956(03)00050-5)
27. Stanley M, Stanley B. 1990 Postmortem evidence for serotonin's role in suicide. J. Clin. Psychiat. 51, 22-28.
28. Mann JJ, Arango V, Marzuk PM, Theccanat S, Reis DJ. 1989 Evidence for the 5-HT hypothesis of suicide: a review of post-mortem studies. Br. J. Psychiat. Suppl. 155(suppl. 8), 7-14.
29. Boldrini M, Underwood MD, Mann JJ, Arango V. 2005 More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res. 1041, 19-28. (doi:10.1016/j.brainres.2005.01.083)
30. Bach-Mizrachi H, Underwood MD, Tin A, Ellis SP, Mann JJ, Arango V. 2008 Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides. Mol. Psychiat. 13, 507-513, 465. (doi:10.1038/sj.mp.4002143)
31. Bonkale WL, Murdock S, Janosky JE, Austin MC. 2004 Normal levels of tryptophan hydroxylase immunoreactivity in the dorsal raphe of depressed suicide victims. J. Neurochem. 88, 958-964.(doi:10.1046/j.1471-4159.2003.02225.x)
32. Mann JJ. 1999 Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21(Suppl. 2), 99S-105S.
33. Shannon C, Schwandt ML, Champoux M, Shoaf SE, Suomi SJ, Linnoila M, Higley JD. 2005 Maternal absence and stability of individual differences in CSF 5-HIAA concentrations in rhesus monkey infants. Am. J. Psychiat. 162, 1658-1664. (doi:10.1176/appi.ajp.162.9.1658)
34. Higley JD, Thompson WW, Champoux M, Goldman D, Hasert MF, Kraemer GW, Scanlan JM, Suomi SJ, Linnoila M. 1993 Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in Rhesus monkeys (Macaca mulatta). Arch. Gen. Psychiat. 50, 615-623. (doi:10.1001/archpsyc.1993.01820200025003)
35. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M. 1987 Cerebrospinal fluid monoamine metabolites levels in male arsonists. Arch. Gen. Psychiat. 44, 241-247. (doi:10.1001/archpsyc.1987.01800150053007)
36. Roy A, Virkkunen M, Guthrie S, Linnoila M. 1986 Indices of serotonin and glucose metabolism in violent offenders, arsonists, and alcoholics. Ann. N Y Acad. Sci. 487, 202-220. (doi:10.1111/j.1749-6632.1986.tb27900.x)
37. Malone KM, Corbitt EM, Li S, Mann JJ. 1996 Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br. J. Psychiat. 168, 324-329. (doi:10.1192/bjp.168.3.324)
38. Coccaro EF, Klar H, Siever LJ. 1994 Reduced prolactin response to fenfluramine challenge in personality disorder patients is not due to deficiency of pituitary lactotrophs. Biol. Psychiat. 36, 344-346.(doi:10.1016/0006-3223(94)90633-5)
39. Keilp JG, Oquendo MA, Stanley BH, Burke AK, Cooper TB, Malone KM, Mann JJ. 2008 Future suicide attempt and responses to serotonergic challenge. Neuropsychopharmacology 35, 1063-1072. (doi:10.1038/npp.2008.28)
40. Arango V, Underwood MD, Mann JJ. 2002 Serotonin brain circuits involved in major depression and suicide. Progr. Brain Res. 136, 443-453. (doi:10.1016/S0079-6123(02)36037-0)
41. Arango V, Underwood MD, Mann JJ. 1997 Postmortem findings in suicide victims. Implications for in vivo imaging studies. Ann. N Y Acad. Sci. 836, 269-287. (doi:10.1111/j.1749-6632.1997.tb52365.x)
42. Damasio H, Grabowski T, Frank R, Galaburda AM, Damasio AR. 1994 The return of Phineas Gage: clues about the brain from the skull of a famous patient. Science 264, 1102-1105. (doi:10.1126/science.8178168)
43. Bechara A, Damasio H, Tranel D, Damasio AR. 1997 Deciding advantageously before knowing the advantageous strategy. Science 275, 1293-1295.(doi:10.1126/science.275.5304.1293)
44. Sellitto M, Ciaramelli E, di Pellegrino G. 2010 Myopic discounting of future rewards after medial orbitofrontal damage in humans. J. Neurosci. 30, 16429-16436. (doi:10.1523/JNEUROSCI.2516-10.2010)
45. Frith CD, Friston K, Liddle PF, Frackowiak RS. 1991 Willed action and the prefrontal cortex in man: a study with PET. Proc. R. Soc. B 244, 241-246.(doi:10.1098/rspb.1991.0077)
46. Leyton M, Paquette V, Gravel P, Rosa-Neto P, Weston F, Diksic M, Benkelfat C. 2006 Alpha- [11C]methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters. Eur. Neuropsychopharmacol. 16, 220-223. (doi:10.1016/j.euroneuro.2005.09.006)
47. Booij L, Turecki G, Leyton M, Gravel P, Lopez De Lara C, Diksic M, Benkelfat C. 2012 Tryptophan hydroxylase(2) gene polymorphisms predict brain serotonin synthesis in the orbitofrontal cortex in humans. Mol. Psychiat. 17, 809-817. (doi:10.1038/mp.2011.79)
48. Oquendo MA et al. 2003 Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch. Gen. Psychiat. 60, 14-22. (doi:10.1001/archpsyc.60.1.14)
49. Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, van Heeringen C, Dierckx RA. 2001 Decreased frontal serotonin 5-HT2a receptor binding index in deliberate self-harm patients. Eur. J. Nucl. Med. 28, 175-182. (doi:10.1007/s002590000392)
50. van Heeringen C, Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, Dierckx RA. 2003 Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J. Affect. Disord. 74, 149-158.(doi:10.1016/S0165-0327(01)00482-7)
51. Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM. 2000 A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol. Psychiat. 47, 540-547. (doi:10.1016/S0006-3223(99)00202-4)
52. Parsey RV, Oquendo MA, Simpson NR, Ogden RT, Van Heertum R, Arango V, Mann JJ. 2002 Effects of sex, age, and aggressive traits in man on brain serotonin 5- HT(1A) receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res. 954, 173-182. (doi:10.1016/S0006-8993(02)03243-2)
53. Frankle WG et al. 2005 Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am. J. Psychiat. 162, 915-923. (doi:10.1176/appi.ajp.162.5.915)
54. Sekine Y et al. 2006 Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch. Gen. Psychiat. 63, 90-100. (doi:10.1001/archpsyc.63.1.90)
55. Soloff PH, Price JC, Meltzer CC, Fabio A, Frank GK, Kaye WH. 2007 5HT2A receptor binding is increased in borderline personality disorder. Biol. Psychiat. 62, 580-587. (doi:10.1016/j.biopsych.2006.10.022)
56. Meyer JH, Wilson AA, Rusjan P, Clark M, Houle S, Woodside S, Arrowood J, Martin K, Colleton M. 2008 Serotonin2A receptor binding potential in people with aggressive and violent behaviour. J. Psychiatr. Neurosci. Jpn 33, 499-508.
57. Brown AK et al. 2007 PET [11C]DASB imaging of serotonin transporters in patients with alcoholism. Alcohol. Clin. Exp. Res. 31, 28-32. (doi:10.1111/j.1530-0277.2006.00261.x)
58. Rubia K, Lee F, Cleare AJ, Tunstall N, Fu CH, Brammer M, McGuire P. 2005 Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI. Psychopharmacology (Berl.) 179, 791-803. (doi:10.1007/s00213-004-2116-z)
59. Soliman A, Bagby RM, Wilson AA, Miler L, Clark M, Rusjan P, Sacher J, Houle S, Meyer JH. 2011 Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits. Psychol. Med. 41, 1051-1060. (doi:10.1017/S0033291710001601)
60. Lewis MD, Hibbeln JR, Johnson JE, Lin YH, Hyun DY, Loewke JD. 2011 Suicide deaths of active-duty US military and omega-3 fatty-acid status: a case-control comparison. J. Clin. Psychiat. 72, 1585-1590. (doi:10.4088/JCP.11m06879)
61. Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ. 2006 Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am. J. Psychiat. 163, 1100-1102. (doi:10.1176/appi.ajp.163.6.1100)
62. Mischoulon D. 2011 The impact of omega-3 fatty acids on depressive disorders and suicidality: can we reconcile 2 studies with seemingly contradictory results? J. Clin. Psychiat. 72, 1574-1576. (doi:10.4088/JCP.11com07463)
63. Sublette ME, Milak MS, Hibbeln JR, Freed PJ, Oquendo MA, Malone KM, Parsey RV, Mann JJ. 2009 Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression. Prostaglandins Leukot. Essent. Fatty Acids 80, 57-64. (doi:10.1016/j.plefa.2008.11.004)
64. Sublette ME, Ellis SP, Geant AL, Mann JJ. 2011 Metaanalysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J. Clin. Psychiat. 72, 1577-1584. (doi:10.4088/JCP.10m06634)
65. Okusaga O, Postolache TT. 2012 Toxoplasma gondii, the immune system, and suicidal behavior. In The Neurobiological basis of suicide (ed. Y Dwivedi). Boca Raton, FL: CRC Press.
66. Postolache TT, Komarow H, Tonelli LH. 2008 Allergy: a risk factor for suicide? Curr. Treat. Options Neurol. 10, 363-376. (doi:10.1007/s11940-008-0039-4)
67. Sublette ME, Postolache TT. 2012 Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway. Psychosom. Med. 74, 668-672. (doi:10.1097/PSY.0b013e318268de9f)
68. Lindqvist D et al. 2009 Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol. Psychiat. 66, 287-292. (doi:10.1016/j.biopsych.2009.01.030)
69. Knoch D, Gianotti LR, Pascual-Leone A, Treyer V, Regard M, Hohmann M, Brugger P. 2006 Disruption of right prefrontal cortex by low-frequency repetitive transcranial magnetic stimulation induces risk-taking behavior. J. Neurosci. 26, 6469-6472.(doi:10.1523/JNEUROSCI.0804-06.2006)
70. Nomura Y, Wickramaratne PJ, Warner V, Mufson L, Weissman MM. 2002 Family discord, parental depression, and psychopathology in offspring: tenyear follow-up. J. Am. Acad. Child. Adolesc. Psychiat. 41, 402-409. (doi:10.1097/00004583-200204000-00012)
71. Holmans P et al. 2007 Genetics of recurrent earlyonset major depression (GenRED): final genome scan report. Am. J. Psychiat. 164, 248-258. (doi:10.1176/appi.ajp.164.2.248)
72. Brodsky BS, Stanley B. 2008 Adverse childhood experiences and suicidal behavior. Psychiat. Clin. North Am. 31, 223-235. (doi:10.1016/j.psc.2008.02.002)
73. Bennett AJ et al. 2002 Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol. Psychiat. 7, 118-122. (doi:10.1038/sj.mp.4000949)
74. Caspi A et al. 2003 Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389. (doi:10.1126/science.1083968)
75. Caspi A et al. 2005 Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-Omethyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiat. 57, 1117-1127. (doi:10.1016/j.biopsych.2005.01.026)
76. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. 2002 Role of genotype in the cycle of violence in maltreated children. Science 297, 851-854. (doi:10.1126/science.1072290)
77. Mann JJ, Haghighi F. 2010 Genes and environment: multiple pathways to psychopathology. Biol. Psychiat. 68, 403-404. (doi:10.1016/j.biopsych.2010.07.006)
78. Moberg T, Nordstrom P, Forslund K, Kristiansson M, Asberg M, Jokinen J. 2011 CSF 5-HIAA and exposure to and expression of interpersonal violence in suicide attempters. J. Affect. Disord. 132, 173-178.(doi:10.1016/j.jad.2011.01.018)
79. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ. 2006 Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31, 1745-1749. (doi:10.1038/sj.npp.1300992)
80. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, Van Heertum Y, Arango V, Mann JJ. 2006 Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol. Psychiat. 59, 106-113. (doi:10.1016/j.biopsych.2005.06.016)
81. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson NR, Huang Y, Van Heertum RL, Arango V, Mann JJ. 2004 Altered serotonin 1A binding in major depression: a [carbonyl-11C]WAY-100635 positron emission tomography study. Arch. Gen. Psychiat. 59, 106-113.
82. Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY, Mann JJ, Parsey RV. 2009 Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biol. Psychiat. 66, 223-230.(doi:10.1016/j.biopsych.2009.01.028)
83. Arango V, Underwood MD, Gubbi AV, Mann JJ. 1995 Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688, 121-133. (doi:10.1016/0006-8993(95)00523-S)
84. Parsey RV, Oquendo MA, Simpson N, Van Heertum R, Arango V, Mann JJ. 2002 Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential using [11C]WAY-100635. Brain Res. 954, 173-182. (doi:10.1016/S0006-8993(02)03243-2)
85. Bonne O et al. 2005 No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder. Am. J. Psychiat. 162, 383-385.(doi:10.1176/appi.ajp.162.2.383)
86. Agid O, Kohn Y, Lerer B. 2000 Environmental stress and psychiatric illness. Biomed. Pharmacother. 54, 135-141. (doi:10.1016/S0753-3322(00)89046-0)
87. Mueser KT, Goodman LB, Trumbetta SL, Rosenberg SD, Osher C, Vidaver R, Auciello P, Foy DW. 1998 Trauma and posttraumatic stress disorder in severe mental illness. J. Consult. Clin. Psychol. 66, 493-499. (doi:10.1037/0022-006X.66.3.493)
88. Arnsten AF. 2009 Stress signalling pathways that impair prefrontal cortex structure and function. Nat. Rev. Neurosci. 10, 410-422. (doi:10.1038/nrn2648)
89. Klemenhagen KC, Gordon JA, David DJ, Hen R, Gross CT. 2006 Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology 31, 101-111.
90. Parsey RV et al. 2006 Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am. J. Psychiat. 163, 52-58. (doi:10.1176/appi.ajp.163.1.52)
91. Miller JM, Hesselgrave N, Ogden RT, Sullivan GM, Oquendo MA, Mann JJ, Parsey RV. In press. PET quantification of serotonin transporter in suicide attempters with major depressive disorder. Biol. Psychiat.
92. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, Rudnick G, Murphy DL. 2003 Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol. Psychiat. 8, 933-936. (doi:10.1038/sj.mp.4001365)
93. Parsey RV et al. 2006 Effect of a triallelic functional polymorphism of the serotonintransporter-linked promoter region on expression of serotonin transporter in the human brain. Am. J. Psychiat. 163, 48-51. (doi:10.1176/appi.ajp.163.1.48)
94. Kinnally EL, Capitanio JP, Leibel R, Deng L, LeDuc C, Haghighi F, Mann JJ. 2010 Epigenetic regulation of serotonin transporter expression and behavior in infant rhesus macaques. Genes Brain Behav. 9, 575-582.
95. Ichise M, Vines DC, Gura T, Anderson GM, Suomi SJ, Higley JD, Innis RB. 2006 Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. J. Neurosci. 26, 4638-4643. (doi:10.1523/JNEUROSCI.5199-05.2006)
96. Miller JM, Kinnally EL, Ogden RT, Oquendo MA, Mann JJ, Parsey RV. 2009 Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder. Synapse 63, 565-573. (doi:10.1002/syn.20637)
97. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ. 1998 Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol. Psychiat. 44, 169-178. (doi:10.1016/S0006-3223(98)00124-3)
98. Underwood MD, Khaibulina AA, Ellis SP, Moran A, Rice PM, Mann JJ, Arango V. 1999 Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol. Psychiat. 46, 473-483.(doi:10.1016/S0006-3223(99)00043-8)
99. Dranovsky A, Hen R. 2006 Hippocampal neurogenesis: regulation by stress and antidepressants. Biol. Psychiat. 59, 1136-1143.(doi:10.1016/j.biopsych.2006.03.082)
100. Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, Mann JJ, Arango V. 2009 Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34, 2376-2389. (doi:10.1038/npp.2009.75)
101. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. 2004 Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306, 879-881. (doi:10.1126/science.1101678)
102. Heinz A et al. 2005 Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 8, 20-21.(doi:10.1038/nn1366)
103. Anand A, Li Y, Wang Y, Lowe MJ, Dzemidzic M. 2009 Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression. Psychiat. Res. 171, 189-198.(doi:10.1016/j.pscychresns.2008.03.012)
104. Beevers CG, Pacheco J, Clasen P, McGeary JE, Schnyer D. 2010 Prefrontal morphology, 5-HTTLPR polymorphism and biased attention for emotional stimuli. Genes Brain Behav. 9, 224-233. (doi:10.1111/j.1601-183X.2009.00550.x)
105. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. 2002 Serotonin transporter genetic variation and the response of the human amygdala. Science 297, 400-403. (doi:10.1126/science.1071829)
106. Miller R, Wankerl M, Stalder T, Kirschbaum C, Alexander N. 2012 The serotonin transporter genelinked polymorphic region (5-HTTLPR) and cortisol stress reactivity: a meta-analysis. Mol. Psychiat. (doi:10.1038/mp.2012.124)
107. Gyurak A, Haase CM, Sze J, Goodkind MS, Coppola G, Lane J, Miller BL, Levenson RW. 2012 The effect of the serotonin transporter polymorphism (5-HTTLPR) on empathic and self-conscious emotional reactivity. Emotion. (doi:10.1037/a0029616)
108. Hamani C et al. 2010 Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol. Psychiat. 67, 117-124. (doi:10.1016/j.biopsych.2009.08.025)